ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in ENDRA Life Sciences Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −2 vs. Q3 2022
- Shares held
- 172.9K
- −4.50K (−2.5%) vs. Q3 2022Converted for a 1-for-20 split
- Total value
- $569.5K
- −$515.5K (−47.5%) vs. Q3 2022
- New holders
- 4
- 2 more added
- Sold out
- 6
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 49,881 | $203.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Morgan Stanley | 43,228 | $175.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 19,202 | $78.0K | 0.00% | +1,952+11.3% | AddedConverted for a 1-for-20 split |
| Dimensional Fund Advisors LP | 15,432 | $63.0K | 0.00% | +15,432 | New |
| Advisor Group Holdings, Inc. | 4,515 | $18.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| JPMorgan Chase & Co | 4,444 | $18.0K | 0.00% | +4,444 | New |
| UBS Group AG | 2,150 | $8.75K | 0.00% | +2,150 | New |
| Royal Bank of Canada | 766 | $3.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Worth Asset Management, LLC | 270 | $1.10K | 0.00% | +60+28.6% | AddedConverted for a 1-for-20 split |
| BlackRock Inc. | 102 | $415 | 0.00% | −1−0.8% | ReducedConverted for a 1-for-20 split |
| GWM Advisors LLC | 32,841 | $134 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Wells Fargo & Company | 22 | $90 | 0.00% | −52−70.4% | ReducedConverted for a 1-for-20 split |
| Bank of America Corp | 6 | $24 | 0.00% | +6 | New |
| Tower Research Capital LLC (TRC) | 46 | $0 | 0.00% | −1,236−96.4% | ReducedConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −14,124−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −5,285−100.0% | Sold outConverted for a 1-for-20 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,798−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,169−100.0% | Sold outConverted for a 1-for-20 split |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −856−100.0% | Sold outConverted for a 1-for-20 split |
| National Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold outConverted for a 1-for-20 split |